New POLARIS Phase I/II data presented at ASGCT show ETX101 gene therapy reducing seizures and improving neurodevelopment in children with SCN1A+ Dravet syndrome.
Throughout this three-part webinar series, experts from USP and industry will share first-hand experiences, case studies, and ...
Genomics and Harvard University have sued Element Biosciences, alleging that Element’s AVITI24™ multiomics platform, Teton ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results